532041 — Hindustan Bio Sciences Income Statement
0.000.00%
Last trade - 00:00- IN₹80.88m
- IN₹102.34m
- IN₹10.53m
Annual income statement for Hindustan Bio Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 9.22 | 10.5 |
| Cost of Revenue | ||
| Gross Profit | 3.52 | 4.1 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 9.56 | 9.96 |
| Operating Profit | -0.339 | 0.57 |
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.379 | 0.533 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -0.405 | 0.576 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.405 | 0.576 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.405 | 0.576 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.039 | 0.056 |
| Dividends per Share |